A Study to Evaluate the Efficacy and Safety of DXP604 in Patients With Mild to Moderate COVID-19

NCT05381519 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: DXP604

Sponsor

Wuhan Institute of Biological Products Co., Ltd